FFO
ANRO icon

Fortitude Family Office’s Alto Neuroscience ANRO Stock Holding History

Fortitude Family Office’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-511
Closed -$9.1K – 2096
2025
Q4 		$9.1K Hold
511
– – ﹤0.01% 606
2025
Q3 		$2.05K Buy
511
+219
+75% +$726 ﹤0.01% 1212
2025
Q2 		$642 Buy
+292
New +$695 ﹤0.01% 1686

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fortitude Family Office's ANRO Position: Q1 2026 in Review

Fortitude Family Office sold out of Alto Neuroscience (ANRO) in Q1 2026, closing a stake of 511 shares — an estimated $9.1K sold.

Fortitude Family Office first reported a position in ANRO in Q2 2025 and held it in 3 quarters. The position peaked at $9.1K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Fortitude Family Office reported no remaining Alto Neuroscience position as of Q1 2026 after selling out during the quarter.
  • Fortitude Family Office sold 511 Alto Neuroscience shares in Q1 2026, an estimated $9.1K.
  • Fortitude Family Office first reported a position in Alto Neuroscience in Q2 2025 and held it in 3 quarters.
  • Fortitude Family Office's Alto Neuroscience position peaked at $9.1K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.